These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22400071)

  • 21. FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways.
    Hu H; Wang F; Wang M; Liu Y; Wu H; Chen X; Lin Q
    Int J Med Sci; 2020; 17(6):807-814. PubMed ID: 32218702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biological behaviors and chemosensitivity of NSCLC A549 cells after IGF-IR gene silencing by targeting RNAi in vitro].
    Kong MJ; Dong AQ; Wu W; Ma ZY; Cheng HF; Qian JF; Fan JQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 37(4):373-80. PubMed ID: 18705010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of TrxR2 suppressed NSCLC cell proliferation, metabolism and induced cell apoptosis through decreasing antioxidant activity.
    Bu L; Li W; Ming Z; Shi J; Fang P; Yang S
    Life Sci; 2017 Jun; 178():35-41. PubMed ID: 28414076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of GINS2 inhibits proliferation and promotes apoptosis through the p53/GADD45A pathway in non-small-cell lung cancer.
    Chi F; Wang Z; Li Y; Chang N
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 27. MiR-875 can regulate the proliferation and apoptosis of non-small cell lung cancer cells via targeting SOCS2.
    Tong JL; Wang LL; Ling XF; Wang MX; Cao W; Liu YY
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5235-5241. PubMed ID: 31298374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition.
    Jin HO; Hong SE; Woo SH; Lee JH; Choe TB; Kim EK; Noh WC; Lee JK; Hong SI; Kim JI; Park IC
    Cell Death Dis; 2012 Jun; 3(6):e319. PubMed ID: 22673193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNA.
    Huang H; Hu YD; Li N; Zhu Y
    Oligonucleotides; 2009 Jun; 19(2):151-62. PubMed ID: 19355812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non‑coding RNA SLNCR1 regulates non‑small cell lung cancer migration, invasion and stemness through interactions with secretory phospholipase A2.
    Xu W; Xu Q; Kuang D; Wang Z; Lu Q; Lin Q; Wu H; Chen L
    Mol Med Rep; 2019 Sep; 20(3):2591-2596. PubMed ID: 31524254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of mTOR Expression by siRNA Leads to Cell Cycle Arrest and Apoptosis Induction in MDA-MB-231 Breast Cancer Cells.
    Sahu R; Jha S; Pattanayak SP
    Curr Gene Ther; 2023; 23(3):228-242. PubMed ID: 36999418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1.
    Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
    Cancer Biomark; 2017 Dec; 21(1):221-228. PubMed ID: 29060934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of mutant K-ras expression by adenovirus-mediated siRNA inhibits the in vitro and in vivo growth of lung cancer cells.
    Zhang Z; Jiang G; Yang F; Wang J
    Cancer Biol Ther; 2006 Nov; 5(11):1481-6. PubMed ID: 17172815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.
    Konstantinidou G; Bey EA; Rabellino A; Schuster K; Maira MS; Gazdar AF; Amici A; Boothman DA; Scaglioni PP
    Cancer Res; 2009 Oct; 69(19):7644-52. PubMed ID: 19789349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
    Lv X; Li CY; Han P; Xu XY
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new strategy in the treatment of chemoresistant lung adenocarcinoma via specific siRNA transfection of SRF, E2F1, Survivin, HIF and STAT3.
    Stoleriu MG; Steger V; Mustafi M; Michaelis M; Cinatl J; Schneider W; Nolte A; Kurz J; Wendel HP; Schlensak C; Walker T
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):877-86. PubMed ID: 24627437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells.
    Huang F; Wu Y; Tan H; Guo T; Zhang K; Li D; Tong Z
    Oncol Rep; 2019 Jan; 41(1):590-598. PubMed ID: 30320343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.